Evidence map›Paper›PMID 32905167›Full record

ArticleExperimental and therapeutic medicine2020

Prevalence of

Alexandra Loor Corojan, Dan-Lucian Dumitrașcu, Petrică Ciobanca, Daniel-Corneliu Leucuta

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 24 citations in OpenAlex.

  1. Resistance to Clarithromycin and Fluoroquinolones inAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Microorganisms · 2025
    Article
  3. Article
  4. Elevated fasting glucose levels associated withJournal of medicine and life · 2025
    Observational
  5. Article
  6. Article
  7. Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Pattern of Primary Resistance ofChildren (Basel, Switzerland) · 2023
    Article
  9. Diagnostics (Basel, Switzerland) · 2023
    Article
  10. Epidemiological Characteristics ofDiagnostics (Basel, Switzerland) · 2023
    Article
  11. Antibiotic Resistance and Therapeutic Efficacy ofAntibiotics (Basel, Switzerland) · 2023
    Article
  12. Sero- and Feco-Prevalence ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  13. Article
  14. The Prevalence of Liver Cytolysis in Children withChildren (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Journal of clinical medicine · 2022
    Article
  17. Experimental and therapeutic medicine · 2021
    Article
  18. Article
  19. Changes in the Seroprevalence ofMedicina (Kaunas, Lithuania) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alexandra Loor CorojanSecond Medical Department, 'Iuliu Hatieganu̓ University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Dan-Lucian DumitrașcuSecond Medical Department, 'Iuliu Hatieganu̓ University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Petrică CiobancaCentral Laboratory, 'Salvosan Ciobanca̓ Medical Center, 450112 Zalau, Romania.
Daniel-Corneliu LeucutaDepartment of Informatics, 'Iuliu Hatieganu̓ University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Iuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection with

Indexed as

anti-Helicobacter pylori antibodiesdyspepsiaHelicobacter pyloriinfectionprevalence

Identifiers

PMID32905167
PMCPMC7464870
OpenAlexW3042843294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.